In a landmark effort to strengthen health security across Southeast Asia, Australia and Thailand have embarked on a transformative partnership that promises to reshape the region’s approach to public health, bringing new hope for resilience. Announced on August 11, this collaboration brings
In a landscape where over 50% of pharmaceuticals distributed in the US are manufactured overseas, the fragility of the drug supply chain has become a pressing concern for national health security, prompting urgent action. Imagine a scenario where a global crisis disrupts access to essential
I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development, as well as a deep understanding of technological innovation in the industry. Today, we’re diving into a groundbreaking advancement in cancer treatment: the recent
In a landscape where economic volatility often shakes investor confidence, Becton Dickinson (BDX) has emerged as a standout performer, recently revising its full-year earnings outlook upward with an adjusted diluted EPS guidance of $14.30 to $14.45, reflecting a robust 9.4% growth at the midpoint.
Imagine a world where a rare, life-altering condition like spinal muscular atrophy (SMA), affecting roughly one in 10,000 newborns globally, can be managed with a simple tablet that doesn’t require refrigeration. This scenario is now a reality for many in the UK with the recent approval of Roche’s
I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development, as well as a deep understanding of technological innovation in the industry. Today, we’re diving into the groundbreaking news about AstraZeneca’s Imfinzi and Imjudo
